1. Home
  2. FFNW vs CRGX Comparison

FFNW vs CRGX Comparison

Compare FFNW & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFNW
  • CRGX
  • Stock Information
  • Founded
  • FFNW 1923
  • CRGX 2021
  • Country
  • FFNW United States
  • CRGX United States
  • Employees
  • FFNW N/A
  • CRGX N/A
  • Industry
  • FFNW Banks
  • CRGX
  • Sector
  • FFNW Finance
  • CRGX
  • Exchange
  • FFNW Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • FFNW 208.8M
  • CRGX 180.4M
  • IPO Year
  • FFNW N/A
  • CRGX 2023
  • Fundamental
  • Price
  • FFNW $22.84
  • CRGX $4.64
  • Analyst Decision
  • FFNW Hold
  • CRGX Hold
  • Analyst Count
  • FFNW 2
  • CRGX 7
  • Target Price
  • FFNW $22.75
  • CRGX $4.67
  • AVG Volume (30 Days)
  • FFNW 78.3K
  • CRGX 653.7K
  • Earning Date
  • FFNW 04-29-2025
  • CRGX 05-13-2025
  • Dividend Yield
  • FFNW 0.57%
  • CRGX N/A
  • EPS Growth
  • FFNW N/A
  • CRGX N/A
  • EPS
  • FFNW 0.12
  • CRGX N/A
  • Revenue
  • FFNW $37,609,000.00
  • CRGX N/A
  • Revenue This Year
  • FFNW N/A
  • CRGX $58.18
  • Revenue Next Year
  • FFNW N/A
  • CRGX N/A
  • P/E Ratio
  • FFNW $195.85
  • CRGX N/A
  • Revenue Growth
  • FFNW N/A
  • CRGX N/A
  • 52 Week Low
  • FFNW $18.03
  • CRGX $3.00
  • 52 Week High
  • FFNW $23.50
  • CRGX $25.45
  • Technical
  • Relative Strength Index (RSI)
  • FFNW 64.00
  • CRGX 59.08
  • Support Level
  • FFNW $22.32
  • CRGX $3.58
  • Resistance Level
  • FFNW $23.05
  • CRGX $4.17
  • Average True Range (ATR)
  • FFNW 0.28
  • CRGX 0.26
  • MACD
  • FFNW -0.02
  • CRGX 0.12
  • Stochastic Oscillator
  • FFNW 73.08
  • CRGX 92.98

About FFNW First Financial Northwest Inc.

First Financial Northwest Inc is the holding company. The Bank's business consists predominantly of attracting deposits from the general public, combined with borrowing from the FHLB of Des Moines and raising funds in the wholesale market then utilizing these funds to originate one-to-four family residential, multifamily, commercial real estate, construction/land, business, and consumer loans. The Bank's strategic initiatives seek to diversify its loan portfolio and broaden growth opportunities with its current risk tolerance levels and asset/liability objectives.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Share on Social Networks: